BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8757473)

  • 1. Heterotopic bone formation in the gastrointestinal tract.
    Haque S; Eisen RN; West AB
    Arch Pathol Lab Med; 1996 Jul; 120(7):666-70. PubMed ID: 8757473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterotopic bone formation in two cases of colon carcinoma.
    Alper M; Akyürek N; Patiroğlu TE; Yüksel O; Belenli O
    Scand J Gastroenterol; 2000 May; 35(5):556-8. PubMed ID: 10868462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
    O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
    Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
    Yacoub L; Goldman H; Odze RD
    Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrent specialized intestinal metaplasia after complete laser ablation.
    Fisher RS; Bromer MQ; Thomas RM; Cohen S; Krevsky B; Horwitz B; Glazier KD; Das K; Das KM
    Am J Gastroenterol; 2003 Sep; 98(9):1945-51. PubMed ID: 14499770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in Barrett's esophagus: short-segment Barrett's esophagus and cardia intestinal metaplasia.
    Sharma P
    Semin Gastrointest Dis; 1999 Jul; 10(3):93-102. PubMed ID: 10435696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
    Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
    Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia.
    Mohammed IA; Streutker CJ; Riddell RH
    Mod Pathol; 2002 Jun; 15(6):611-6. PubMed ID: 12065774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of short segment Barrett's esophagus with intestinal metaplasia in stomach.
    Tuncer I; Ugraş S; Uygan I; Türkdoğan K; Kösem M
    Turk J Gastroenterol; 2003 Mar; 14(1):33-8. PubMed ID: 14593535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
    Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
    Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
    Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
    Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osseous metaplasia in benign colorectal polyps.
    Groisman GM; Benkov KJ; Adsay V; Dische MR
    Arch Pathol Lab Med; 1994 Jan; 118(1):64-5. PubMed ID: 8285834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine osseous metaplasia.
    Bhatia NN; Hoshiko MG
    Obstet Gynecol; 1982 Aug; 60(2):256-9. PubMed ID: 6818502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Heterotopic ossification in the skeletal muscle metastases of advanced stomach cancer].
    Fujiwara R; Saga T; Akashi N; Takegoshi T; Saitoh K; Tokuda T; Kitoh C; Ichiyanagi K; Doishita K
    Gan No Rinsho; 1983 Oct; 29(12):1471-5. PubMed ID: 6417371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histochemical analysis of estrogen and progesterone receptors and gastric-type mucin in mucinous ovarian tumors with reference to their pathogenesis.
    Shiohara S; Shiozawa T; Shimizu M; Toki T; Ishii K; Nikaido T; Fujii S
    Cancer; 1997 Sep; 80(5):908-16. PubMed ID: 9307191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is Barrett's esophagus associated with intestinal metaplasia of the gastric cardia?
    Morales TG; Bhattacharyya A; Johnson C; Sampliner RE
    Am J Gastroenterol; 1997 Oct; 92(10):1818-22. PubMed ID: 9382043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
    Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
    Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
    Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
    Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.